TAKANASHI KEN
SEC CIK 1657768 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| WVE | Wave Life Sciences, Inc. | Dir, 10% | 20.1K | — | $65.9K | 5 | 2024-08-12 | 2026-08-11 |
Most active insiders at WVE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | $54.63M | — |
| 2 | GSK plc | 10% | $27.93M | — |
| 3 | Francis Chris | See Remarks | — | $7.10M |
| 4 | Moran Kyle | CFO | — | $4.15M |
| 5 | Tan Aik Na | Dir | — | $1.83M |
| 6 | HENRY CHRISTIAN O | Dir | — | $1.37M |
| 7 | Rawcliffe Adrian | Dir | — | $806.6K |
| 8 | Verdine Gregory L. | Dir | — | $269.5K |
| 9 | Wagner Heidi L | Dir | — | $231.1K |
| 10 | CORRIGAN MARK | Dir | — | $217.3K |
| 13 | TAKANASHI KEN | Dir | — | $23.2K |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-13 21:00 | 2026-08-11 | WVE | Wave Life Sciences, Inc. | TAKANASHI KEN | Dir | S - Sale | $6.01 | -3,864 | 20.1K | -16% | -$23.2K |
| DI | 2026-03-26 | 2026-03-23 | WVE | Wave Life Sciences, Inc. | TAKANASHI KEN | Dir | C - Cnv Deriv | $0.00 | +3.90M | 9.61M | +68% | $0 |
| D | 2025-08-13 | 2025-08-11 | WVE | Wave Life Sciences, Inc. | TAKANASHI KEN | Dir | A - Grant | $0.00 | +12.7K | 5.73M | +0.2% | $0 |
| T | 2025-08-07 | 2025-08-05 | WVE | Wave Life Sciences, Inc. | TAKANASHI KEN | Dir | S - Sale | $8.75 | -4,872 | 5.72M | -0.1% | -$42.6K |
| D | 2024-08-14 | 2024-08-12 | WVE | Wave Life Sciences, Inc. | TAKANASHI KEN | Dir, 10% | A - Grant | $0.00 | +16.1K | 5.72M | +0.3% | $0 |
Purchase Sale Sale after option exercise All abbreviations